SUSQUEHANNA INTERNATIONAL GROUP, LLP - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$189,030
-44.5%
93,579
-19.0%
0.00%
Q2 2023$340,840
-10.7%
115,539
-24.3%
0.00%
Q1 2023$381,543
-35.5%
152,617
-18.2%
0.00%
Q4 2022$591,471
+4.1%
186,584
-2.2%
0.00%
Q3 2022$568,000
-82.1%
190,803
-81.7%
0.00%
Q2 2022$3,173,000
-77.3%
1,040,361
+0.4%
0.00%
-100.0%
Q1 2022$13,993,000
-54.9%
1,036,540
-56.4%
0.00%
Q4 2021$30,996,000
+507.1%
2,378,750
+337.0%
0.00%
Q3 2021$5,106,000
-16.4%
544,309
-8.7%
0.00%
Q2 2021$6,106,000596,3650.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 714,763$2,265,7992.16%
Perceptive Advisors 4,797,278$15,207,3710.43%
Potomac Capital Management, Inc. 80,000$2540.30%
Bristlecone Advisors, LLC 696,629$2,208,3140.27%
TANG CAPITAL MANAGEMENT LLC 485,234$1,538,1920.22%
RA Capital Management 1,881,300$5,963,7210.12%
GSA CAPITAL PARTNERS LLP 270,989$8590.11%
PATHSTONE FAMILY OFFICE, LLC 3,631,080$8,182,6500.07%
Laird Norton Wetherby Trust Company, LLC 130,000$412,1000.06%
Forefront Analytics, LLC 22,350$70,8510.04%
View complete list of ATHIRA PHARMA INC shareholders